Gary Herman was appointed Director of Wellgistics Health, Inc. As of November 14, 2026, Wellgistics Health, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from February 5, 2026 to February 9, 2026, naming 1 appointment (Form 8-K, February 9, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Wellgistics Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Wellgistics Health, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-05 to 2026-02-09. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Wellgistics Health, Inc. files it.
Also on the record for Wellgistics Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 10, 2026 | IPO filing, Form S-1/A | — | IPO filings | Source |
| November 10, 2026 | Stake report, Schedule 13G, by Hyperscale Data, Inc. | 9.99% of the class | 5%+ stakes | Source |
| October 9, 2026 | IPO filing, Form S-1/A | — | IPO filings | Source |
| August 7, 2026 | IPO filing, Form S-1 | — | IPO filings | Source |
| September 29, 2025 | IPO filing, Form 424B4 | $0.7 a share | IPO filings | Source |
| September 22, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| September 12, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| August 29, 2025 | IPO filing, Form S-1/A | — | IPO filings | Source |
| July 24, 2025 | IPO filing, Form S-1 | — | IPO filings | Source |
| May 5, 2025 | IPO filing, Form S-1 | — | IPO filings | Source |
| February 21, 2025 | IPO filing, Form 424B4 | $4.5 a share | IPO filings | Source |
| January 14, 2025 | IPO filing, Form S-1/A | $4.5 to $5.5 a share | IPO filings | Source |
Selling to them or working with them? See who runs Wellgistics Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Wellgistics Health, Inc. and the records around it.
Wellgistics Health, Inc. elsewhere on the record
- IPO filing Nov 2026
- Who owns it
Companies that share a holder
- Hyperscale Data, Inc. also filed stake reports on 4 other companies: Powell Max Ltd (Nov 2026), UNIVERSAL SAFETY PRODUCTS, INC. (Oct 2026), YY Group Holding Ltd. (Aug 2026)
Watch Wellgistics Health, Inc.
Get an email when Wellgistics Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Wellgistics Health, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Wellgistics Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Wellgistics Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 19 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-02-09 | In | Director | 8-K, 2026-02-09 | ||
| 2026-02-05 | Reported | not named in the filing | 8-K, 2026-02-05 |
Who leads Wellgistics Health, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Gary Herman, appointed (filed 2026-02-09).
New leaders reset buying decisions — get the Full Report on Wellgistics Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Wellgistics Health, Inc., with the record behind each one.
Find candidates like Director at Wellgistics Health, Inc.Every change, in the filing's words
Appointed: Gary Herman, Director
The board of directors has since appointed Mr. Herman to serve as the chairman on the Audit Committee of the board of directors.
- Election of Directors Effective as of February 4, 2026, the remaining member of the board of directors acted by consent in lieu of a meeting of the board of directors under Section 141(f) of the DGCL to elect Gary Herman (the "Newly Elected Director") to the board of directors to serve as directors.
- Mr. Herman will be an "independent" director as defined under applicable rules of NASDAQ and the SEC.
- Pursuant to the policies of the Company, each non-employee director will receive an annual cash retainer of $120,000, payable at the director's election in cash or shares of Common Stock.
- These retainers are paid quarterly in arrears on or before the fifteenth (15th) business day following the end of each calendar quarter.
- Each non-employee director also receives an annual equity award of 60,000 shares of Common Stock under the Company's Amended and Restated 2023 Equity Incentive Plan.
- These shares of Common Stock are to be issued annually in arrears on or before the fifteenth (15th) business day following the end of each calendar year.
- Non-employee directors are also reimbursed for reasonable travel expenses in connection with their attendance at board of director and committee meetings.
- Upon appointment, each non-employee directors will receive 200,000 restricted shares of Common Stock, vesting in equal installments over three (3) years.
Reported
Director Resignations On February 1, 2026, Steven Lee advised the Company that he was resigning from his position as a member of the board of directors effective immediately.
- Mr. Lee indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
- At the time of his resignation, Mr. Lee served on the Ethics Committee.
- On February 1, 2026, Howard Doss advised the Company that he was resigning from his position as a member of the board of directors effective immediately.
- Mr. Doss indicated that his decision to resign was not a result of his of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices.
- At the time of his resignation, Mr. Doss served as chairman on the Audit Committee.
Tools for this story
Each opens in a new tab, filled in for Wellgistics Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
